Pages that link to "Q40502995"
Jump to navigation
Jump to search
The following pages link to Radiosensitization of colon cancer cell lines by docetaxel: mechanisms of action (Q40502995):
Displaying 7 items.
- KPU-300, a Novel Benzophenone-Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase (Q28551906) (← links)
- Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies (Q34462887) (← links)
- Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions (Q36747219) (← links)
- Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy. (Q37002044) (← links)
- Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial (Q40121242) (← links)
- Docetaxel-based preoperative chemoradiation in localized gastric cancer: impact of pathological complete response on patient outcome (Q46321335) (← links)
- Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis (Q93083941) (← links)